CenturyLink Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-8,086
Closed -$451K 32
2020
Q1
$451K Buy
+8,086
New +$494K 0.29% 126
2017
Q4
Sell
-13,333
Closed -$850K 158
2017
Q3
$850K Buy
13,333
+33
+0.2% +$1.93K 0.28% 153
2017
Q2
$741K Sell
13,300
-17,282
-57% -$940K 0.25% 161
2017
Q1
$1.66M Hold
30,582
0.54% 74
2016
Q4
$1.79M Sell
30,582
-2,066
-6% -$113K 0.61% 49
2016
Q3
$1.76M Hold
32,648
0.6% 55
2016
Q2
$2.4M Hold
32,648
0.85% 21
2016
Q1
$2.09M Buy
32,648
+4,040
+14% +$255K 0.76% 32
2015
Q4
$1.97M Hold
28,608
0.69% 32
2015
Q3
$1.69M Sell
28,608
-781
-3% -$49.5K 0.55% 40
2015
Q2
$1.96M Sell
29,389
-601
-2% -$39.6K 0.65% 36
2015
Q1
$1.93M Sell
29,990
-802
-3% -$50.2K 0.64% 36
2014
Q4
$1.82M Hold
30,792
0.54% 48
2014
Q3
$1.58M Sell
30,792
-3,101
-9% -$155K 0.53% 60
2014
Q2
$1.64M Hold
33,893
0.51% 67
2014
Q1
$1.76M Sell
33,893
-7,444
-18% -$396K 0.57% 47
2013
Q4
$2.2M Sell
41,337
-8,326
-17% -$424K 0.68% 34
2013
Q3
$2.3M Sell
49,663
-14,111
-22% -$619K 0.7% 28
2013
Q2
$2.85M Buy
+63,774
New +$2.77M 0.83% 19

Other funds holding BMY

CenturyLink Investment Management's BMY Position: Q2 2020 in Review

CenturyLink Investment Management sold out of Bristol-Myers Squibb (BMY) in Q2 2020, closing a stake of 8,086 shares — an estimated $451K sold.

CenturyLink Investment Management first reported a position in BMY in Q2 2013 and held it in 19 quarters. The position peaked at $2.85M in Q2 2013. 2,189 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

  • CenturyLink Investment Management reported no remaining Bristol-Myers Squibb position as of Q2 2020 after selling out during the quarter.
  • CenturyLink Investment Management sold 8,086 Bristol-Myers Squibb shares in Q2 2020, an estimated $451K.
  • CenturyLink Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 19 quarters.
  • CenturyLink Investment Management's Bristol-Myers Squibb position peaked at $2.85M in Q2 2013.
  • 2,189 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on CenturyLink Investment Management's 13F filing for Q2 2020, filed 9 Jul 2020.